UPDATE 1-France’s Sanofi to carve out active drug ingredients firm
Sanofi plans to create a
standalone company dedicated to making active pharmaceutical
ingredients (API), components that are biologically active in a
drug, and will decide whether to list it on Euronext Paris by
2022.
standalone company dedicated to making active pharmaceutical
ingredients (API), components that are biologically active in a
drug, and will decide whether to list it on Euronext Paris by
2022.
Posted by Reuters
